Fidelity MSCI Health Care Index ETF (FHLC)
| 61.42 Delayed Data As of Jul 01 |  +0.75 / +1.24%Today’s Change | 55.92 Today|||52-Week Range 69.27 | -10.54% Year-to-Date |
Investment Objective
The investment seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the MSCI USA IMI Health Care 25/50 Index. The fund invests at least 80% of assets in securities included in the fund's underlying index. The fund's underlying index is the MSCI USA IMI Health Care 25/50 Index, which represents the performance of the health care sector in the U.S. equity market. It may or may not hold all of the securities in the MSCI USA IMI Health Care 25/50 Index. The fund is non-diversified.
Latest FHLC News
No recent news for Fidelity MSCI Health Care Index ETF.
Performance
| 1 month | +0.56% | 3 years | +12.32% | |
| 3 months | -7.03% | 5 years | +11.67% | |
| 1 year | -3.22% | Since inception | +12.52% |
Data through 07/02/2022
Quote Details
| Previous close | $60.67 |
| Open day’s range | 60.12 – 61.49 |
| Net asset value (NAV) | 61.45 (07/01/2022) |
| Daily volume | 103,282 |
| Average volume (3 months) | 183,350 |
Data as of 3:59pm ET, 07/01/2022
Peer Comparisonvs. Health ETFs
| FHLC | Category | |
|---|---|---|
| Performance 5-yr return | +11.67% | +11.31% |
| Expense Gross exp ratio | 0.08% | 1.01% |
| Risk 5 year sharpe ratio | 0.80 | 0.52 |
| Net assets | $2.8B | $1.9B |
| Average market cap | $93.0B | $43.0B |
| Average P/E | 22.3 | 22.2 |
| Dividend / Share | -- | 0.27% |
Competitors
| VHT Vanguard Health Care Index Fund ETF Shar... |
| IEHS iShares Evolved U.S. Healthcare Staples ... |
| PPH VanEck Pharmaceutical ETF |
Holdings
Top 5 SectorsPortfolio weighting
| Business service | -- |
| Consumer goods | -- |
| Consumer service | -- |
| Energy | -- |
| Financial service | -- |
Top 10 HoldingsPortfolio weighting
| JNJ Johnson & Johnson | 8.19% |
| UNH UnitedHealth | 8.11% |
| PFE Pfizer | 5.16% |
| ABBV AbbVie | 4.52% |
| LLY Eli Lilly and Co | 4.42% |
| MRK Merck | 4.03% |
| TMO Thermo Fisher Scientific Inc | 3.88% |
| ABT Abbott Laboratories | 3.60% |
| DHR Danaher Corp | 2.94% |
| BMY Bristol-Myers Squibb | 2.90% |
